Linda Groenendijk
Contact details
Linda's research focuses on enhancing drug delivery approaches in in vitro cancer models, with a particular emphasis on neuroblastoma. The aim is to optimize how drugs are introduced into these systems by refining dosing strategies, combination protocols, and treatment schedules. A key aspect of this work involves incorporating patient-specific pharmacokinetic data to better mimic clinically relevant drug exposures. By improving the physiological relevance of in vitro models, Linda seeks to develop more predictive and translational platforms for preclinical drug testing.
- Publications